학술논문
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
Document Type
Article
Author
Pignata, S.; Bookman, M.; Sehouli, J.; Miller, A.; Penson, R.T.; Taskiran, C.; Anderson, C.; Hietanen, S.; Myers, T.; Madry, R.; Willmott, L.; Lortholary, A.; Thomes-Pepin, J.; Aghajanian, C.; McCourt, C.; Stuckey, A.; Wu, X.; Nishio, S.; Copeland, L.J.; He, Y.; Molinero, L.; Patel, S.; Lin, Y.G.; Khor, V.K.; Moore, K.N.
Source
In: Gynecologic Oncology . (Gynecologic Oncology, October 2023, 177:20-31)
Subject
Language
English
ISSN
10956859
00908258
00908258